Skip to content
10-K

Annual Report

MARIMED INC. MRMD

0001522767-26-000030

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 10, 2026 397.88M sh
Shares Diluted FY 2025 · Dec 31, 2025 390.14M sh
Shares Diluted FY 2025 · Dec 31, 2024 379.15M sh
Capex FY 2025 · Dec 31, 2025 $1.17M
Capex FY 2025 · Dec 31, 2024 $11.96M
Operating Cash Flow FY 2025 · Dec 31, 2025 $7.7M
Operating Cash Flow FY 2025 · Dec 31, 2024 $6.79M
Long Term Debt FY 2025 · Dec 31, 2025 $76.04M
Current Liabilities FY 2025 · Dec 31, 2025 $59.07M
Current Liabilities restated FY 2025 · Dec 31, 2024 $50.01M
Total Liabilities FY 2025 · Dec 31, 2025 $137.83M
Total Liabilities restated FY 2025 · Dec 31, 2024 $129.44M
Current Assets FY 2025 · Dec 31, 2025 $59.29M
Current Assets FY 2025 · Dec 31, 2024 $53.51M
Total Assets FY 2025 · Dec 31, 2025 $202.57M
Total Assets FY 2025 · Dec 31, 2024 $206.99M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.04
Eps Diluted FY 2025 · Dec 31, 2024 −$0.03
Eps Basic FY 2025 · Dec 31, 2025 −$0.04
Eps Basic FY 2025 · Dec 31, 2024 −$0.03
Net Income FY 2025 · Dec 31, 2025 −$14.48M
Net Income restated FY 2025 · Dec 31, 2024 −$12.47M
Operating Income FY 2025 · Dec 31, 2025 −$2.82M
Operating Income restated FY 2025 · Dec 31, 2024 $2.61M
Gross Profit FY 2025 · Dec 31, 2025 $57.88M
Gross Profit restated FY 2025 · Dec 31, 2024 $62.61M
Cost Of Revenue FY 2025 · Dec 31, 2025 $101.95M
Cost Of Revenue FY 2025 · Dec 31, 2024 $95.1M
Revenue FY 2025 · Dec 31, 2025 $159.83M
Revenue restated FY 2025 · Dec 31, 2024 $157.71M